Home > Insider Trading > Cymabay Therapeutics Inc.

Cymabay Therapeutics Inc. (CBAY)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Third Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 9th, 2023 - News Transcripts

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q2 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Second Quarter 2023 Financial Results and Business Update Conference Call.

Keep Reading →

August 13th, 2023 - News Transcripts

5 Best Medical Stocks Under $10

In this piece, we will take a look at the five best medical stocks under $10.

Keep Reading →

June 24th, 2023 - News

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

May 17th, 2023 - News Transcripts

5 Best Biotech Stocks to Buy Under $20

Biohaven Ltd. (NYSE:BHVN) is an American company headquartered in New Haven, Connecticut.

Keep Reading →

March 21st, 2023 - News

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q4 2022 Earnings Call Transcript

Operator: Good day ladies and gentlemen and welcome to CymaBay's Fourth Quarter and Full-Year 2022 Financial Results and Business Update Conference Call.

Keep Reading →

March 20th, 2023 - News Transcripts

5 Best Biotech Stocks Under $10

In this article, we will look at the 5 best biotech stocks under $10.

Keep Reading →

September 26th, 2022 - Hedge Funds News

10 Best Biotech Stocks Under $10

In this article, we will take a look at the 10 best Biotech stocks under $10.

Keep Reading →

September 1st, 2022 - Hedge Funds News

Hedge Fund and Insider Trading News: Anthony Scaramucci, Ken Griffin, Clint Carlson, Renaissance Technologies, EcoR1 Capital, Lodbrok Capital, Phillips 66 Partners LP (PSXP), and More

New York - US regulators have rejected former White House communications director Anthony Scaramucci's hedge fund's filing to list a bitcoin exchange-traded fund.

Keep Reading →

January 21st, 2022 - Hedge Funds Insider Trading